- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Carcinomas in Canada
Total 1814 results
-
University of Western Ontario, CanadaCompletedNeuroendocrine Carcinoma (Carcinoid)Canada
-
Lawson Health Research InstituteActive, not recruiting
-
Sunnybrook Health Sciences CentreMerck KGaA, Darmstadt, GermanyCompleted
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
CHU de Quebec-Universite LavalRecruitingNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid TumorCanada
-
Sunnybrook Health Sciences CentreCompletedCarcinoma, NeuroendocrineCanada
-
National Cancer Institute (NCI)CompletedMetastatic Gastrointestinal Carcinoid Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Pulmonary Carcinoid TumorCanada
-
University of ManitobaCompletedBrain Tumor | Neuroendocrine CancerCanada
-
British Columbia Cancer AgencyWithdrawnNeuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid TumorCanada
-
AHS Cancer Control AlbertaTerminatedRenal Cell Carcinoma | Neuroendocrine TumoursCanada
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
University of Western Ontario, CanadaTerminatedNeuroendocrine Tumors | Carcinoid TumorsCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaRecruitingMelanoma | Breast Cancer | Gastrointestinal Neuroendocrine TumorCanada
-
Alberta Health servicesRecruiting
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedNeuroendocrine Tumors | Pancreatic Neuroendocrine TumorsCanada
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditionsCanada
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedMelanoma | Lymphoma | Lymphoma, Non-Hodgkin | Carcinoma, Basal CellCanada
-
National Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine TumorUnited States, Canada
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
British Columbia Cancer AgencyWithdrawnLocally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)Canada
-
Incyte CorporationActive, not recruitingMetastatic Merkel Cell CarcinomaUnited Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
-
British Columbia Cancer AgencyRecruitingPituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary CarcinomaCanada
-
Vancouver Coastal HealthUnknownNeuroblastoma | Pheochromocytoma | Paraganglioma | Medullary Thyroid Carcinoma | Carcinoid TumorsCanada
-
Ocellaris Pharma, Inc.RecruitingSarcoma | Neoplasms | Renal Cell Carcinoma | Cervical Cancer | Cancer | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Squamous... and other conditionsCanada
-
AdaptimmuneCompletedMelanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial CarcinomaUnited States, Canada, Spain
-
University of AlbertaRecruiting
-
University Health Network, TorontoCompleted
-
Centre de recherche du Centre hospitalier universitaire...Université de SherbrookeRecruiting
-
University Health Network, TorontoActive, not recruitingNeuroendocrine TumorsCanada
-
Centre de recherche du Centre hospitalier universitaire...Completed
-
Sunnybrook Health Sciences CentreMerck KGaA, Darmstadt, GermanyUnknown
-
University Health Network, TorontoCompletedNeuroendocrine TumorsCanada
-
University of AlbertaRecruitingNeuroendocrine TumorsCanada
-
AHS Cancer Control AlbertaRecruiting
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Tumor G1 | Metastatic Carcinoid Tumor | Recurrent Digestive System Neuroendocrine Tumor G1 | Regional Digestive System Neuroendocrine Tumor G1 | Midgut Neuroendocrine Tumor G1 | Foregut Neuroendocrine Tumor | Hindgut Neuroendocrine Tumor | Neuroendocrine...Canada, United States
-
Jennerex BiotherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoCancer Care Ontario; Ozmosis Research Inc.; Canadian Molecular Imaging Probe...Active, not recruitingNeuroendocrine TumorsCanada
-
British Columbia Cancer AgencyCompleted
-
Centre hospitalier de l'Université de Montréal...Active, not recruitingNon Small Cell Lung Cancer Metastatic | Advanced MelanomaCanada
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
ExelixisActive, not recruitingMedullary Thyroid CancerAustralia, France, Israel, Spain, Russian Federation, Netherlands, Hungary, Korea, Republic of, Croatia, Italy, Canada, Poland, Romania, Sweden